Comparative Effectiveness for AI MedTech

Comparative Effectiveness for AI MedTech

Comparative Effectiveness for AI MedTechNicole Coustier
Published on: 04/09/2024

Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.

Payer Coverage
What U.S. Payers are Saying About AI MedTech

What U.S. Payers are Saying About AI MedTech

What U.S. Payers are Saying About AI MedTechNicole Coustier
Published on: 27/08/2024

What AI MedTech founders need to know about payer expectations and evidence standards.

Payer Coverage
The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival

The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival

The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech SurvivalNicole Coustier
Published on: 03/08/2024

Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.

U.S. Healthcare Fundamentals
What Do Payers Mean by “Clinical Utility”?

What Do Payers Mean by “Clinical Utility”?

What Do Payers Mean by “Clinical Utility”?Nicole Coustier
Published on: 01/06/2024

“Clinical utility” is one of the most misunderstood payer terms. This article explains what U.S. payers expect and how to prepare.

Evidence Planning